Younger onset myeloperoxidase-specific antineutrophil cytoplasmic antibody-(MPO-ANCA) related glomerulonephritis accompanied with nephrotic syndrome

被引:0
|
作者
Kaneko, Y
Kamijo, Y
Kobayashi, N
Higuchi, M
Ehara, T
Hora, K
Shigematsu, H
Kiyosawa, K
机构
[1] Shinshu Univ, Sch Med, Dept Internal Med 2, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 390, Japan
[3] Shinshu Univ, Sch Med, Div Blood Purificat, Matsumoto, Nagano 390, Japan
关键词
anti-neutrophil cytoplasmic antibody (ANCA) crescent; double nephropathy; nephrotic syndrome; rapidly progressive glomerulonephritis; younger onset;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
It is known that nephrotic syndrome rarely accompanies myeloperoxidase-specific antineutrophil cytoplasmic antibody- (MPO-ANCA) related glomerulonephritis. We present a case of younger onset MPO-ANCA-related glomerulonephritis accompanied with nephrotic syndrome in a female patient. It was diagnosed through the renal biopsy and the detection of a high titer of MPO-ANCA and steroid therapy (intravenous steroid pulse therapy and oral administration), anticoagulant therapy and antiplatelet therapy were initiated. Since her nephrotic syndrome persisted in spite of the decrease of MPO-ANCA, we conducted a second renal biopsy. We found active necrotizing crescentic glomerulonephritis with a small deposition of immunoglobulin and fibrinogen on the glomeruli. To suppress her disease activity, we administered second steroid-pulse therapy and MPO-ANCA titer disappeared. However, as her nephrotic syndrome, which was accompanied by severe hyperlipidemia, persisted, we tried to treat her using low-density lipoprotein (LDL) apheresis. It was effective temporarily, but she finally fell into end-stage renal failure. We discuss here the possibility of double nephropathy by considering her clinical and renal pathologic features.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 50 条
  • [21] A Panel Set for Epitope Analysis of Myeloperoxidase (MPO)-Specific Antineutrophil Cytoplasmic Antibody MPO-ANCA Using Recombinant Hexamer Histidine-Tagged MPO Deletion Mutants
    Kazuo Tomizawa
    Eriko Mine
    Asami Fujii
    Yuko Y. Ohashi
    Satoshi Yamagoe
    Yuki Hashimoto
    Akiko Ishida-Okawara
    Mie Ito
    Masaru Tanokura
    Takeki Yamamoto
    Yoshihiro Arimura
    Toshihiko Nagasawa
    Satoshi Mizuno
    Kazuo Suzuki
    Journal of Clinical Immunology, 1998, 18 : 142 - 152
  • [22] A pilot-controlled study of myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) in the coronary circulation
    Ramadan, Mahmoud M.
    Tachikawa, Hitoshi
    Kodama, Makoto
    Okawara, Akiko
    Mitsuma, Wataru
    Ito, Masahiro
    Kashimura, Takeshi
    Ikrar, Taruna
    Hirono, Satoru
    Okura, Yuji
    Suzuki, Kazuo
    Aizawa, Yoshifusa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 128 (01) : 114 - 116
  • [23] A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants
    Tomizawa, K
    Mine, E
    Fujii, A
    Ohashi, YY
    Yamagoe, S
    Hashimoto, Y
    Ishida-Okawara, A
    Ito, M
    Tanokura, M
    Yamamoto, T
    Arimura, Y
    Nagasawa, T
    Mizuno, S
    Suzuki, K
    JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (02) : 142 - 152
  • [24] A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy
    Michiko Shimada
    Takeshi Fujita
    Norio Nakamura
    Ikuyo Narita
    Yuko Shimaya
    Reiichi Murakami
    Hideaki Yamabe
    Hiroshi Osawa
    Ken Okumura
    BMC Nephrology, 14
  • [25] Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA)
    Nakamori, Y
    Tominaga, T
    Inoue, Y
    Shinohara, K
    INTERNAL MEDICINE, 2003, 42 (06) : 529 - 533
  • [26] Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis
    O'Sullivan, Kim M.
    Lo, Camden Y.
    Summers, Shaun A.
    Elgass, Kirstin D.
    McMillan, Paul J.
    Longano, Anthony
    Ford, Sharon L.
    Gan, Poh-Yi
    Kerr, Peter G.
    Kitching, A. Richard
    Holdsworth, Stephen R.
    KIDNEY INTERNATIONAL, 2015, 88 (05) : 1030 - 1046
  • [27] A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy
    Shimada, Michiko
    Fujita, Takeshi
    Nakamura, Norio
    Narita, Ikuyo
    Shimaya, Yuko
    Murakami, Reiichi
    Yamabe, Hideaki
    Osawa, Hiroshi
    Okumura, Ken
    BMC NEPHROLOGY, 2013, 14
  • [28] De novo myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis 31 years after living-donor kidney transplantation
    Haruyama, Naoki
    Tsuchimoto, Akihiro
    Masutani, Kosuke
    Noguchi, Hideko
    Suehiro, Takaichi
    Kitada, Hidehisa
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    CEN CASE REPORTS, 2015, 4 (01): : 14 - 19
  • [29] De novo myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis 31 years after living-donor kidney transplantation
    Naoki Haruyama
    Akihiro Tsuchimoto
    Kosuke Masutani
    Hideko Noguchi
    Takaichi Suehiro
    Hidehisa Kitada
    Kazuhiko Tsuruya
    Takanari Kitazono
    CEN Case Reports, 2015, 4 (1) : 14 - 19
  • [30] Rapidly progressive glomerulonephritis in rheumatoid arthritis patients induced by D-penicillamine is associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA); Retrospective study on induction of MPO-ANCA by use of D-penicillamine.
    Terai, C
    Koseki, Y
    Moriguchi, M
    Uesato, M
    Taniguchi, A
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S351 - S351